Advertisement
Advertisement
OFIX
Orthofix Medical Inc. Common Stock (DE)
8.22
USDSponsored
-0.70
-7.85%
Nov 06, 11:55 UTC -5
Open
Orthofix Medical Inc. Common Stock (DE) (OFIX) Earnings
OFIX Earnings Reports
Positive Surprise Ratio
OFIX beat 34 of 43 last estimates.
79%
Next Report
Next Week
Date of Next Report
Nov 09, 2026
Estimate for Q3 26 (Revenue/ EPS)
$214.73M
/-$0.27
Implied change from Q2 26 (Revenue/ EPS)
+1.80%
/-30.77%
Implied change from Q3 25 (Revenue/ EPS)
+4.42%
/-51.79%
Orthofix Medical Inc. Common Stock (DE) earnings per share and revenue
On Aug 05, 2026, OFIX reported earnings of -0.39 USD per share (EPS) for Q2 26, beating the estimate of -0.41 USD, resulting in a 6.74% surprise. Revenue reached 210.93 million, compared to an expected 213.46 million, with a -1.19% difference. The market reacted with a -14.59% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 5 analysts forecast an EPS of -0.27 USD, with revenue projected to reach 214.73 million USD, implying an decrease of -30.77% EPS, and increase of 1.80% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Tandem Diabetes Care, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.24
Actual
-$0.10
Surprise
+59.55%
Artivion, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.06
Actual
$0.08
Surprise
+228.00%
Mobia Medical, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.47
Actual
-$0.52
Surprise
-9.04%
Treace Medical Concepts, Inc. Common Stock
Report Date
Nov 06, 2026 For Q3 26
Estimate
-$0.25
Actual
-$0.19
Surprise
+26.67%
Inogen Inc
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.14
Actual
-$0.56
Surprise
-285.41%
Envoy Medical, Inc. Class A Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.68
Actual
-$0.50
Surprise
+26.47%
Mettler-Toledo International
Report Date
Nov 05, 2026 For Q3 26
Estimate
$12.21
Actual
$12.57
Surprise
+2.90%
Teleflex Incorporated
Report Date
Nov 05, 2026 For Q3 26
Estimate
$1.92
Actual
$2.63
Surprise
+36.82%
Pulse Biosciences, Inc Common Stock (DE)
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.37
Actual
-$0.32
Surprise
+14.05%
TransMedics Group, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.29
Actual
$0.51
Surprise
+71.31%
FAQ
What were Orthofix Medical Inc. Common Stock (DE)'s earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Orthofix Medical Inc. Common Stock (DE) reported EPS of -$0.39, beating estimates by 6.74%, and revenue of $210.93M, -1.19% below expectations.
How did the market react to Orthofix Medical Inc. Common Stock (DE)'s Q2 2026 earnings?
The stock price moved down -14.59%, changed from $12.20 before the earnings release to $10.42 the day after.
When is Orthofix Medical Inc. Common Stock (DE) expected to report next?
The next earning report is scheduled for Nov 09, 2026.
What are the forecasts for Orthofix Medical Inc. Common Stock (DE)'s next earnings report?
Based on 5
analysts, Orthofix Medical Inc. Common Stock (DE) is expected to report EPS of -$0.27 and revenue of $214.73M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.